We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
10 Year Est. Return
AUM
$230M
AUM Growth
+$15.6M
Cap. Flow
+$5.46M
Cap. Flow %
2.37%
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$1.45M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.42M
3
G icon
Genpact
G
+$1.42M
4
CHRW icon
C.H. Robinson
CHRW
+$1.34M
5
OGE icon
OGE Energy
OGE
+$1.31M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.44M
2
MDLZ icon
Mondelez International
MDLZ
+$1.42M
3
AVT icon
Avnet
AVT
+$1.21M
4
MRVL icon
Marvell Technology
MRVL
+$1.04M
5
XYZ
Block Inc
XYZ
+$987K

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Consumer Discretionary 15.35%
3 Healthcare 13.63%
4 Industrials 12.99%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DUOL icon
26
Duolingo
DUOL
$5.87B
$1.16M 0.5%
2,827
+1,226
+77% +$538K
AEP icon
27
American Electric Power
AEP
$68.8B
$1.15M 0.5%
11,069
+7,268
+191% +$756K
MET icon
28
MetLife
MET
$62.3B
$1.15M 0.5%
14,239
+7,753
+120% +$598K
BJ icon
29
BJs Wholesale Club
BJ
$12.4B
$1.14M 0.49%
+10,561
New +$1.2M
WFC icon
30
Wells Fargo
WFC
$262B
$1.13M 0.49%
14,145
+6,826
+93% +$492K
WDAY icon
31
Workday
WDAY
$44.2B
$1.1M 0.48%
+4,565
New +$1.11M
EXEL icon
32
Exelixis
EXEL
$13.2B
$1.09M 0.48%
24,843
+10,649
+75% +$426K
AYI icon
33
Acuity Brands
AYI
$10.8B
$1.07M 0.46%
+3,586
New +$928K
ADBE icon
34
Adobe
ADBE
$106B
$1.05M 0.46%
+2,719
New +$1.05M
CAH icon
35
Cardinal Health
CAH
$55.8B
$1.05M 0.46%
+6,259
New +$929K
LYFT icon
36
Lyft
LYFT
$6.48B
$1.05M 0.45%
66,331
-25,643
-28% -$359K
DLB icon
37
Dolby
DLB
$5.77B
$1.03M 0.45%
13,912
+5,308
+62% +$397K
HAYW icon
38
Hayward Holdings
HAYW
$3.37B
$1.01M 0.44%
73,297
+34,664
+90% +$467K
GGG icon
39
Graco
GGG
$13.5B
$997K 0.43%
+11,597
New +$961K
MSI icon
40
Motorola Solutions
MSI
$78B
$995K 0.43%
2,367
+1,111
+88% +$465K
JHG
41
DELISTED
Janus Henderson
JHG
$967K 0.42%
24,891
+1,837
+8% +$64.7K
AVAV icon
42
AeroVironment
AVAV
$8.95B
$966K 0.42%
+3,389
New +$574K
HAS icon
43
Hasbro
HAS
$13.1B
$954K 0.41%
12,929
+3,811
+42% +$240K
ISRG icon
44
Intuitive Surgical
ISRG
$133B
$950K 0.41%
1,748
+707
+68% +$370K
AS icon
45
Amer Sports
AS
$21.4B
$950K 0.41%
24,502
+7,721
+46% +$238K
ZM icon
46
Zoom
ZM
$30.6B
$949K 0.41%
12,172
+5,872
+93% +$454K
HBAN icon
47
Huntington Bancshares
HBAN
$35.3B
$949K 0.41%
+56,597
New +$854K
GILD icon
48
Gilead Sciences
GILD
$166B
$947K 0.41%
8,540
+142
+2% +$15.1K
KMX icon
49
CarMax
KMX
$8.29B
$935K 0.41%
+13,906
New +$935K
YUM icon
50
Yum! Brands
YUM
$41.3B
$926K 0.4%
+6,249
New +$912K

Similar funds

Sherbrooke Park Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
  • Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
  • Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
  • Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
  • Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
  • Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
  • Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.